$220 Million is the total value of PURA VIDA INVESTMENTS, LLC's 77 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGN | New | ALLERGAN PLCput | $22,782,000 | – | 85,000 | +100.0% | 10.36% | – |
| NUVA | New | NUVASIVE INCcall | $5,838,000 | – | 120,000 | +100.0% | 2.65% | – |
| ABT | New | ABBOTT LABS | $5,229,000 | – | 125,000 | +100.0% | 2.38% | – |
| AET | New | AETNA INC NEW | $4,494,000 | – | 40,000 | +100.0% | 2.04% | – |
| ATHN | New | ATHENAHEALTH INC | $4,163,000 | – | 30,000 | +100.0% | 1.89% | – |
| SPY | New | SPDR S&P 500 ETF TRcall | $4,110,000 | – | 20,000 | +100.0% | 1.87% | – |
| SHPG | New | SHIRE PLCsponsored adr | $3,997,000 | – | 23,250 | +100.0% | 1.82% | – |
| AMGN | New | AMGEN INC | $3,834,000 | – | 25,575 | +100.0% | 1.74% | – |
| IVC | New | INVACARE CORP | $2,963,000 | – | 225,000 | +100.0% | 1.35% | – |
| MCK | New | MCKESSON CORP | $2,909,000 | – | 18,500 | +100.0% | 1.32% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INCcall | $2,796,000 | – | 100,000 | +100.0% | 1.27% | – |
| TFX | New | TELEFLEX INCput | $2,355,000 | – | 15,000 | +100.0% | 1.07% | – |
| MYL | New | MYLAN N V | $2,039,000 | – | 44,000 | +100.0% | 0.93% | – |
| SRPT | New | SAREPTA THERAPEUTICS INCput | $1,952,000 | – | 100,000 | +100.0% | 0.89% | – |
| BIIB | New | BIOGEN INC | $1,952,000 | – | 7,500 | +100.0% | 0.89% | – |
| CELG | New | CELGENE CORP | $1,914,000 | – | 19,125 | +100.0% | 0.87% | – |
| CNC | New | CENTENE CORP DEL | $1,879,000 | – | 30,524 | +100.0% | 0.85% | – |
| MDVN | New | MEDIVATION INC | $1,713,000 | – | 37,250 | +100.0% | 0.78% | – |
| AMRN | New | AMARIN CORP PLCspons adr new | $1,664,000 | – | 1,087,500 | +100.0% | 0.76% | – |
| IVC | New | INVACARE CORPcall | $1,647,000 | – | 125,000 | +100.0% | 0.75% | – |
| HTWR | New | HEARTWARE INTL INC | $1,571,000 | – | 50,000 | +100.0% | 0.71% | – |
| OPHT | New | OPHTHOTECH CORP | $1,374,000 | – | 32,500 | +100.0% | 0.62% | – |
| ANGO | New | ANGIODYNAMICS INCcall | $1,229,000 | – | 100,000 | +100.0% | 0.56% | – |
| SGNT | New | SAGENT PHARMACEUTICALS INC | $1,092,000 | – | 89,713 | +100.0% | 0.50% | – |
| FLDM | New | FLUIDIGM CORP DEL | $1,009,000 | – | 125,000 | +100.0% | 0.46% | – |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $979,000 | – | 7,500 | +100.0% | 0.44% | – |
| FOLD | New | AMICUS THERAPEUTICS INCcall | $845,000 | – | 100,000 | +100.0% | 0.38% | – |
| NXTM | New | NXSTAGE MEDICAL INCcall | $750,000 | – | 50,000 | +100.0% | 0.34% | – |
| CPXX | New | CELATOR PHARMACEUTICALS INC | $607,000 | – | 55,000 | +100.0% | 0.28% | – |
| VNDA | New | VANDA PHARMACEUTICALS INC | $564,000 | – | 67,500 | +100.0% | 0.26% | – |
| IMMU | New | IMMUNOMEDICS INC | $181,000 | – | 72,500 | +100.0% | 0.08% | – |
| HTBX | New | HEAT BIOLOGICS INC | $167,000 | – | 240,815 | +100.0% | 0.08% | – |
| OCUL | New | OCULAR THERAPEUTIX INC | $58,000 | – | 6,000 | +100.0% | 0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 26 | Q2 2023 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
| INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
| ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
| Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
| Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
| Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
| MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
| INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
| MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
| TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| SC 13D/A | 2023-12-29 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.